GlassScriptPhysician profile
David C Majors
NPI 1619157658
$29,889.51
in general payments reported to CMS, 2019-2025
14 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $565 · 2020: $12K · 2021: $1,594 · 2022: $2,194 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,993.75 |
| Food and Beverage | $140.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| International Rehabilitative Sciences, INC | $29,221.44 | 2020-2025 | Rs-4i Plus With Intersperse |
| Daiichi Sankyo INC. | $161.38 | 2019 | |
| Scilex Pharmaceuticals INC. | $99.08 | 2019 | |
| Collegium Pharmaceutical, INC. | $97.48 | 2019 | |
| Boston Scientific Corporation | $94.14 | 2019-2022 | |
| Electronic Waveform Lab, INC. | $49.12 | 2019 | |
| Kaleo, INC. | $45.45 | 2019 | |
| Shionogi INC | $28.10 | 2019 | |
| Pacira Therapeutics, INC. | $27.35 | 2020 | |
| Abbott Laboratories | $18.09 | 2019 | |
| Arbor Pharmaceuticals, INC. | $16.84 | 2019 | |
| Sentynl Therapeutics, INC. | $14.40 | 2019 | |
| Lilly USA, LLC | $11.20 | 2019 | |
| Fidia Pharma USA INC. | $5.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Majors listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.